India: Hub for Lung Cancer Trials

India has been opted as the hub for lung cancer trials as Roche has set up clinical trial sites here as part of its global study for treatment of a particular variant of lung cancer.

India has been opted as the hub for lung cancer trials as Swiss pharma major Roche has set up clinical trial sites here as part of its global study for treatment of a particular variant of lung cancer.  Eli Lilly is also engaged in human studies in oncology and is developing a new molecule for lung cancer.

The just concluded observance of lung cancer month in November has brought to light that global pharma cannot ignore India for clinical trials.  The main reason is a vast patient population infected by a type of lung cancer, which is primarily triggered by use of tobacco products,  according to Dr. Ajay Gupta, Medical Oncologist, MAX Hospital.

Among the notable on-going human studies for lung cancer in India according to Dr. Gupta are a clinical t